World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
32058
World Ranking
12599
National Ranking
517

Jordan J. Feld publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jordan J. Feld sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 627 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jordan J. Feld D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jordan J. Feld sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jordan J. Feld is affiliated with the University Health Network in Canada and has a research profile primarily centered on medicine, with a focus on epidemiology, hepatology, infectious diseases, immunology, and oncology.

Their frequent publication venues include:

  • Journal of Hepatology
  • Canadian Liver Journal
  • Journal of Viral Hepatitis
  • Hepatology
  • Clinical Infectious Diseases

Jordan J. Feld's research topics cover several areas within liver disease and viral infections, specifically:

  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Hepatitis Viruses Studies and Epidemiology
  • HIV, Drug Use, Sexual Risk
  • SARS-CoV-2 and COVID-19 Research

Among the recent papers authored by Jordan J. Feld are:

  • Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial, 2021, The Lancet Respiratory Medicine

Frequent co-authors in their collaborative research include:

  • Harry L.A. Janssen
  • Bettina E. Hansen
  • Mia J. Biondi
  • Adam J. Gehring
  • Milan J. Sonneveld

The intersection of Jordan J. Feld's work is largely focused on viral hepatitis and liver diseases, where they contribute to epidemiological studies and clinical research. Their involvement spans several subfields, with notable emphasis on epidemiology and hepatology.

The work also encompasses research around SARS-CoV-2 and COVID-19, particularly with clinical trials related to interferon treatments in outpatient settings. This indicates active participation in infectious disease research alongside chronic liver conditions.

Best Publications

  • Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

    Adriaan J. van der Meer;Bart J. Veldt;Jordan J. Feld;Heiner Wedemeyer

  • Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

    Ira M. Jacobson;Stuart C. Gordon;Kris V. Kowdley;Eric M. Yoshida

  • Mechanism of action of interferon and ribavirin in treatment of hepatitis C

    Jordan J. Feld;Jay H. Hoofnagle

  • Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

    Jordan J. Feld;Ira M. Jacobson;Christophe Hézode;Tarik Asselah

  • Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

    Jordan J. Feld;Kris V. Kowdley;Eoin Coakley;Samuel Sigal

  • Residual NADPH oxidase and survival in chronic granulomatous disease.

    Douglas B. Kuhns;W. Gregory Alvord;Theo Heller;Jordan J. Feld

  • Hepatic Gene Expression Discriminates Responders and Nonresponders in Treatment of Chronic Hepatitis C Viral Infection

    Limin Chen;Ivan Borozan;Jordan Feld;Jing Sun

  • Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

    Graham S Cooke;Isabelle Andrieux-Meyer;Tanya L Applegate;Rifat Atun

  • Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

    Stefan Zeuzem;Graham R Foster;Stanley Wang;Armen Asatryan

  • Extrahepatic Morbidity and Mortality of Chronic Hepatitis C

    Francesco Negro;Daniel Forton;Antonio Craxì;Mark S. Sulkowski

  • Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.

    Jordan J. Feld;Huong Dinh;Tamara Arenovich;Victoria A. Marcus

  • From non-A, non-B hepatitis to hepatitis C virus cure

    Jean Michel Pawlotsky;Jean Michel Pawlotsky;Jordan J. Feld;Stefan Zeuzem;Jay H. Hoofnagle

  • Clinical trial: pilot study of metformin for the treatment of non‐alcoholic steatohepatitis

    R. Loomba;G. Lutchman;D. E. Kleiner;M. Ricks

  • Increased caffeine consumption is associated with reduced hepatic fibrosis

    Apurva A. Modi;Jordan J. Feld;Jordan J. Feld;Yoon Park;David E. Kleiner

  • Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.

    Golo Ahlenstiel;Rachel H. Titerence;Christopher Koh;Birgit Edlich

  • Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response†

    Jordan J. Feld;Santosh Nanda;Ying Huang;Weiping Chen

  • Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores

    George N. Ioannou;George N. Ioannou;Lauren A. Beste;Pamela K. Green;Amit G. Singal

  • Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis.

    K. Rajender Reddy;Marc Bourlière;Mark Sulkowski;Masao Omata

  • Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.

    Jason Grebely;Olav Dalgard;Brian Conway;Evan B Cunningham

  • Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

    Ira M. Jacobson;Ira M. Jacobson;Eric Lawitz;Edward J. Gane;Bernard E. Willems

Frequent Co-Authors

Gregory J. Dore
Gregory J. Dore University of New South Wales
Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam
Margaret Hellard
Margaret Hellard Burnet Institute
Gail V. Matthews
Gail V. Matthews University of New South Wales
Jason Grebely
Jason Grebely University of New South Wales
Edward Gane
Edward Gane Auckland City Hospital
Janaki Amin
Janaki Amin Macquarie University
Kyong-Mi Chang
Kyong-Mi Chang University of Pennsylvania
Adrian M. Di Bisceglie
Adrian M. Di Bisceglie Saint Louis University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in pathways related to medicine but seek more flexible study options, there are numerous online degrees and certifications to consider. For aspiring nurses, affordability is a key concern—explore the cheapest rn to bsn programs to transition from Registered Nurse to Bachelor of Science in Nursing without incurring heavy debt.

Those from non-nursing backgrounds can fast-track a nursing career through direct entry msn programs, allowing graduates to gain advanced standing and leadership roles in the field. Additionally, many look for flexible options and higher acceptance rates; online adn programs for non nurses offer an accessible entry point into nursing.

For those interested in the administrative side of healthcare, accredited programs in medical billing and coding offer strong job prospects. Find programs that fit your budget by checking medical billing and coding schools that accept financial aid. These options make healthcare careers more accessible and diverse for students with varied backgrounds and goals.

Best Scientists Citing Jordan J. Feld

Trending Scientists

Recently Published Articles